Back

Redefining the Bladder Cancer Phenotype using Patterns of Familial Risk

Hanson, H. A.; Leiser, C. L.; Martin, C.; Gupta, S.; Smith, K. R.; Dechet, C.; Lowrance, W.; O'Neil, B.; Camp, N. J.

2019-08-16 epidemiology
10.1101/19003681 medRxiv
Show abstract

Relatives of bladder cancer (BCa) patients have been shown to be at increased risk for kidney, lung, thyroid, and cervical cancer after correcting for smoking related behaviors that may concentrate in some families. We demonstrate a new method to simultaneously assess risks for multiple cancers to identify distinct multi-cancer configurations (multiple different cancer types that cluster in relatives) surrounding BCa patients. We identified 6,416 individuals with urothelial carcinoma and familial information using the Utah Cancer Registry and Utah Population Database (UPDB). First-degree relatives, second-degree relatives, and first cousins were used to construct a familial enrichment matrix for cancer-types previously shown to be individually associated with BCa. K-medioids clustering were used to identify Familial Multi-Cancer Configurations (FMC). A case-control design and Cox regression with a 1:5 ratio of BCa cases to cancer-free controls was used to quantify the risk in specific relative-types and spouses in each FMC. Clustering analysis revealed 12 distinct FMCs, each exhibiting a different pattern of cancer co-aggregation. Of the 12 FMCs, four exhibited strong familial risk of bladder cancer along with specific patterns of increased risk of cancers in other sites (BCa FMCs), and were the focus of further investigation. Cancers at increased risk in these four BCa FMCs most commonly included melanoma, prostate and breast cancer and less commonly included leukemia, lung, pancreas and kidney cancer. A network-based approach can be used with familial data to discover new phenotype clusters for BCa, providing new directions for discovering patterns of cancer clustering.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.1%
33.3%
2
Scientific Reports
3102 papers in training set
Top 3%
12.6%
3
PLOS ONE
4510 papers in training set
Top 27%
6.4%
50% of probability mass above
4
Nature Communications
4913 papers in training set
Top 28%
6.4%
5
Nucleic Acids Research
1128 papers in training set
Top 4%
4.9%
6
PLOS Computational Biology
1633 papers in training set
Top 11%
3.1%
7
eLife
5422 papers in training set
Top 35%
2.1%
8
Genome Medicine
154 papers in training set
Top 3%
2.1%
9
International Journal of Epidemiology
74 papers in training set
Top 1%
1.8%
10
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.3%
1.7%
11
Bioinformatics
1061 papers in training set
Top 7%
1.7%
12
Cancers
200 papers in training set
Top 3%
1.7%
13
Communications Biology
886 papers in training set
Top 12%
1.3%
14
Science Advances
1098 papers in training set
Top 26%
0.9%
15
American Journal of Epidemiology
57 papers in training set
Top 1%
0.8%
16
Genetic Epidemiology
46 papers in training set
Top 0.8%
0.8%
17
Cell Reports Methods
141 papers in training set
Top 5%
0.8%
18
Epidemiology
26 papers in training set
Top 0.6%
0.7%
19
NAR Genomics and Bioinformatics
214 papers in training set
Top 4%
0.7%
20
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 47%
0.7%
21
Frontiers in Genetics
197 papers in training set
Top 12%
0.5%
22
Cell Genomics
162 papers in training set
Top 8%
0.5%
23
IEEE Journal of Biomedical and Health Informatics
34 papers in training set
Top 3%
0.5%